WESTERN ANIMAL(300106)

Search documents
西部牧业:下属花园乳业、天山云牧乳业均拥有奶粉生产线且正常生产
Zheng Quan Ri Bao Zhi Sheng· 2025-09-05 11:13
Core Viewpoint - Western Dairy announced on September 5 that its subsidiaries, Huayuan Dairy and Tianshan Yunmu Dairy, have operational milk powder production lines and are producing normally [1] Group 1: Company Operations - The company’s dairy processing enterprises are committed to continuous product research and development [1] - The company is actively expanding sales channels to enhance product sales [1]
西部牧业:截至8月29日公司的股东总数为2.43万户
Zheng Quan Ri Bao Wang· 2025-09-04 11:14
证券日报网讯西部牧业(300106)9月4日在互动平台回答投资者提问时表示,截至8月29日公司的股东 总数为2.43万户。 ...
西部牧业:公司自产生鲜乳生产量为2540.33吨
Zheng Quan Ri Bao Wang· 2025-09-04 07:10
证券日报网讯9月3日晚间,西部牧业(300106)发布公告称,2025年8月份,公司自产生鲜乳生产量为 2,540.33吨。 ...
A股乳业股逆势上涨,均瑶健康涨超7%,骑士乳业涨超6%
Ge Long Hui A P P· 2025-09-04 06:06
| 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 300892 | 品屋食品 | | 8.88 | 38.85亿 | 21.72 | | 605388 | 均瑶健康 | | 7.28 | 54.88 Z | 46.75 | | 832786 | 骑士乳业 | 1 | 6.65 | 23.48 Z | 59.97 | | 300898 | 態猫乳品 | 1 | 5.21 | 36.07亿 | 15.40 | | 002570 | 贝因美 | 1 | 4.64 | 75.50亿 | 66.03 | | 002719 | 麦趣尔 | 兼 | 4.19 | 16.46亿 | 20.69 | | 300106 | 西部收业 | + | 3.89 | 24.81亿 | 33.71 | | 002910 | 庄园牧场 | | 3.81 | 19.16亿 | 30.15 | | 300915 | 海融科技 | | 3.56 | 32.60亿 | 13.85 | | 002329 | 皇氏集团 | | 3.55 | 31. ...
9连板天普股份明起停牌核查;永安药业董事长陈勇解除留置丨公告精选
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-03 14:19
Key Points - Tianpu Co., Ltd. announced a suspension of trading for stock verification due to multiple instances of abnormal trading fluctuations from August 22 to September 3, with a reminder for investors about market risks [1] - China Shipbuilding Industry Corporation announced a share exchange ratio of 1:0.1339 for the merger with China Shipbuilding, with the stock ceasing to be listed from September 5, 2025 [2] - Chengdu Huamei reported that its 40G high-precision RF ADC chip is still in the trial production stage and has not achieved mass sales, indicating market demand uncertainty [2] - Taihe Technology's sulfide solid electrolyte project is currently in the trial production phase and has not generated sales revenue [3] - Robotech signed a contract worth approximately €946.50 million for fully automated silicon photonic packaging equipment, expected to positively impact the company's future performance [4] - Wento Holdings reported that its cinema and gaming businesses are still in the recovery phase post-restructuring, with potential uncertainties in future operations [5] - Xibu Muye's fresh milk production increased by 4.8% month-on-month in August [6] - China Shipbuilding announced the implementation of a share exchange merger with China Heavy Industry [6] - Gansu Energy plans to invest CNY 40.89 billion in a wind-solar integrated project [6] - Xinhua Medical's endoscope cleaning workstation received a Class II medical device registration certificate [6]
西部牧业:8月自产生鲜乳生产量2540.33吨,同比减少7.27%
Bei Jing Shang Bao· 2025-09-03 13:38
北京商报讯(记者 孔文燮)9月3日,西部牧业晚间公告,8月公司自产生鲜乳生产量为2540.33吨,环比 增长4.8%,同比减少7.27%。 ...
9月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-03 10:18
Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]
西部牧业:8月自产生鲜乳生产量环比增长4.8%
Zheng Quan Shi Bao Wang· 2025-09-03 08:24
人民财讯9月3日电,西部牧业(300106)9月3日晚间公告,8月公司自产生鲜乳生产量为2540.33吨,环 比增长4.8%,同比减少7.27%。 ...
西部牧业8月自产生鲜乳生产量同比下降7.27%
Zhi Tong Cai Jing· 2025-09-03 08:23
西部牧业(300106)(300106.SZ)披露自产生鲜乳销售情况,公司2025年8月自产生鲜乳生产量2540.33 吨,同比下降7.27%。 ...
西部牧业(300106.SZ)8月自产生鲜乳生产量同比下降7.27%
智通财经网· 2025-09-03 08:21
智通财经APP讯,西部牧业(300106.SZ)披露自产生鲜乳销售情况,公司2025年8月自产生鲜乳生产量 2540.33吨,同比下降7.27%。 ...